Johnson Controls Q2 sales +13% organic; adj. EPS $0.75 (+19% YoY); backlog record $11.7B

Johnson Controls International plc

2023-Q2 EPS reported $0.36 revenue$12,754,000,000

GAAP EPS $0.19; adjusted EPS $0.75, up 19% YoY; adjusted net income $517M (+17%).
Q2 sales $6.7B, +10% as reported, +13% organic; orders +8% organically; record backlog $11.7B.
Adjusted EBIT $716M, margin 10.7% (up 70 bps); GAAP EBIT $294M, margin 4.4%.
Initiates Q3 guidance and updates FY2023 full-year guidance; FY23 outlook raised.
CEO cites double-digit growth and healthy pipeline; CFO says results exceeded high end of guidance.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Johnson Controls International plc reported fiscal second quarter 2023 results: revenue $6.7 billion, net income $133 million, EPS GAAP EPS of $0.19.

Period: fiscal second quarter 2023
Revenue: $6.7 billion
Net income: $133 million
EPS: GAAP EPS of $0.19
Result: reported results

Exact text from the filing

Johnson Controls International plc (NYSE: JCI), a global leader for smart, healthy and sustainable buildings, today reported fiscal second quarter 2023 GAAP earnings per share (“EPS”) from continuing operations of $0.19. Excluding special items, adjusted EPS from continuing operations was $0.75, up 19% versus the prior year period (see attached footnotes for non-GAAP reconciliation). Sales in the quarter of $6.7 billion increased 10% compared to the prior year on an as reported basis and grew 13% organically. GAAP net income from continuing operations was $133 million.

View on SEC.gov

Browse all earnings releases →

Johnson Controls International plc filing history →

Source: SEC EDGAR

accession 0000833444-23-000011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.